CPEB4 Activators would refer to a collection of chemical agents designed to enhance the activity of the Cytoplasmic Polyadenylation Element Binding Protein 4 (CPEB4). CPEB4 is an RNA-binding protein that is part of the CPEB family, which plays a crucial role in the regulation of mRNA translation. This family of proteins typically binds to specific sequences within the 3' untranslated regions (UTRs) of mRNAs and influences their polyadenylation status, which in turn can affect mRNA stability and the efficiency of translation initiation. CPEB4, like its family members, is implicated in the control of gene expression at the post-transcriptional level, modulating the translation of a subset of mRNAs in response to cellular signals. Activators of CPEB4 would thus interact with the protein or its associated molecular complex to enhance its RNA-binding activity or stabilization of the protein, leading to an increase in the translation of mRNAs under its control. The discovery and development of such activators would involve screening assays that can detect the interaction between CPEB4 and its target mRNAs, or assays that can measure the extent of polyadenylation and translation of these mRNAs.
Following the initial identification of CPEB4 Activators, detailed biochemical and biophysical studies would be conducted to ascertain their precise mechanism of action. These studies would likely involve the use of techniques such as electrophoretic mobility shift assays (EMSAs) to observe the binding affinity between CPEB4 and RNA in the presence of the activators, and ribonuclease protection assays to assess the protection of RNA from degradation. Additionally, the structure-function relationship of CPEB4 in the presence of the activators would be an area of focus, potentially employing X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy to gain insight into any conformational changes that enhance its activity. Advanced imaging techniques, such as single-molecule fluorescence microscopy, could be used to visualize the interaction dynamics of CPEB4 and RNA in real-time. These comprehensive studies would not only inform on the activators' mode of action but also contribute to a broader understanding of the regulation of mRNA translation and the precise role of CPEB4 in cellular function. Understanding how CPEB4 Activators modulate the activity of this protein could provide valuable insights into the complex network of RNA-protein interactions that govern gene expression at the post-transcriptional level.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is known to affect glycogen synthase kinase 3 (GSK-3) signaling, which may indirectly influence CPEB4 expression through pathways affecting mRNA stability and translation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound is a DNA methyltransferase inhibitor, which can lead to the hypomethylation of genes and potentially upregulate CPEB4 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Sodium butyrate is a histone deacetylase inhibitor that can increase the acetylation of histones, leading to a more relaxed chromatin structure and potentially higher CPEB4 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Similar to sodium butyrate, trichostatin A is a histone deacetylase inhibitor that could enhance CPEB4 transcription by altering chromatin accessibility. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a major component of green tea with various biological effects; it can modulate signaling pathways and might influence CPEB4 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol affects various signaling pathways including SIRT1 and AMPK, which could potentially lead to the modulation of CPEB4 expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
As a steroid hormone, estradiol can modulate gene expression via estrogen receptors, potentially affecting CPEB4 expression in hormone-responsive tissues. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Vitamin D3 modulates gene expression through the vitamin D receptor (VDR), which might influence CPEB4 expression in some cell types. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid, through its interaction with retinoic acid receptors, can regulate gene expression and may alter the levels of CPEB4. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin activates several signaling pathways such as PI3K/Akt that could influence CPEB4 expression in metabolically active tissues. |